|
- 2016
慢性乙型肝炎患者外周血CD4+CD25+CD127low/-调节性T细胞表达及其与肝组织病理、HBV-cccDNA的关系
|
Abstract:
摘要:目的 探讨慢性乙型肝炎(CHB)患者外周血CD4+CD25+CD127low/-调节性T细胞与肝组织HBV-cccDNA及HBV-DNA载量、血清HBV-DNA载量、肝脏病理及肝功能的相关性。方法 采用流式细胞仪检测30例CHB及30例健康体检者外周血CD4+CD25+CD127low/-调节性T细胞占CD4+T细胞百分率;并对其中22例患者行肝组织活检,采用实时荧光定量聚合酶链反应(FQ-PCR)检测CHB患者肝组织HBV-cccDNA、HBV-DNA载量;肝组织进行苏木素-伊红(HE)染色、Masson染色、网染、VG染色,行炎症(G)分级及纤维化(S)分期;同期检测肝功能ALT水平,并对各检测值进行比较和相关性分析。结果 CHB患者外周血CD4+CD25+CD127low/-Treg细胞的百分率为(9.27±2.07)%,明显高于健康对照组(4.96±0.97)%,差异具有统计学意义(P<0.05);CHB患者外周血CD4+CD25+CD127low/-Treg细胞与血清HBV DNA(lgIU/mL)载量呈正相关(Pearson相关系数r=0.38, P<0.05);与肝组织HBV-cccDNA及HBV-DNA(lgcps/mg)均无明显相关性(Pearson相关系数r分别为0.162、0.306,两者均P>0.05);与肝组织炎症级别及纤维化分期均无明显相关性(Spearman秩相关系数r分别为0.056、-0.047,两者均为P>0.05);与ALT亦无明显相关性(Pearson相关系数r=0.044,P>0.05)。结论 慢性乙型肝炎患者外周血CD4+CD25+CD127low/-Treg细胞水平明显升高且与血清HBV-DNA载量呈正相关,提示Treg细胞在慢性乙型肝炎中发挥着重要的负性免疫调节作用,可能是导致病毒复制持续存在的重要因素。
ABSTRACT: Objective To investigate the expression level of CD4+CD25+CD127low/- regulatory T cells in the peripheral blood of patients with chronic hepatitis B (CHB) and its association with liver HBV-cccDNA and HBV-DNA, HBV-DNA of the peripheral blood, liver pathology and liver function. Methods We enrolled 30 CHB patients and 30 healthy controls. The percentage of peripheral blood CD4+CD25+CD127low/- regulatory T cells in CD4+ T cells were detected by flow cytometry. And 22 patients underwent liver biopsy; the quantities of intrahepatic HBV cccDNA and HBV DNA were detected by real-time fluorescent quantitative PCR. The liver tissue was dyed with HE dyeing, Masson dyeing, Nets dyeing and VG dyeing. Inflammatory grading and fibrosis staging were performed. The level of alanine aminotransferase (ALT) was collected simultaneously. Results The frequency of the peripheral blood CD4+CD25+CD127low/-Treg in CHB was (9.27±2.07)%, which was significantly higher than that in healthy controls [(4.96±0.97)%, P<0.05]. The peripheral blood CD4+CD25+CD127low/-?? Treg in CHB was positively correlated with the plasma HBV DNA (lgIU/mL) (r=0.38, P<0.05), and there was no significant correlation with the level of liver inflammation or fibrosis stage (r=0.056, -0.047 respectively, both P>0.05). Also there were no significant correlation with ALT (r=0.044, P>0.05). Conclusion The expression of CD4+CD25+CD127low/- regulatory T cells in the peripheral blood of CHB patients increased significantly, which suggested that Tregs plays a negative role in immune regulation of CHB and may be an important factor of the persistence of viral replication
[1] | 程爱荣,程焱,孙保亮,等. 调节性T细胞及其免疫抑制机制[J]. 中国临床神经科学, 2014, 22(4):438-444. |
[2] | 郑盛. 慢性乙型肝炎病毒感染者外周血CD4<sup>+</sup>CD25<sup>+</sup>CD127<sup>(low/-)</sup>调节性T淋巴细胞表达水平及其与肝脏病理关系[J]. 西部医学, 2014, 26(9):1137-1140. |
[3] | JOSEFOWICZ SZ, LU LF, RUDENSKY AY, et al. Regulatory T cells: mechanisms of differentiation and function[J]. Ann Rev Immunol,2012, 30:531-564. |
[4] | CHRUSCINSKI A, SADOZAI H, ROIAS-LUENQAS V, et al. Role of regulatory T cells (Treg) and the Treg effector molecule fibrinogen-like protein 2 in alloimmunity and autoimmunity[J]. Rambam Maimonides Med J, 2015, 6(3):e0024. |
[5] | O’CONNOR RA, ANDERTON SM. Foxp3+ regulatory T cells in the control of experimental CNS autoimmune disease[J]. J Neuroimmunol, 2008, 193(1-2):1-11. |
[6] | HAIQI H, YONG Z, YI L, et al. Transcriptional regulation of Foxp3 in regulatory T cells[J]. Immunobiology, 2011, 216(6):678-685. |
[7] | MORGAN ME, VANBILSEN JH, BAKKER AM, et al. Expression of FOXP3 mRNA is not confined to CD4<sup>+</sup>CD25<sup>+</sup> T regulatory cells in humans[J]. Hum Immunol, 2005, 66(1):13-20. |
[8] | NAN XP, ZHONG Y, YU HT, et al. Circulating CD4<sup>+</sup>CD25high regulatory T cells and expression of PD-1 and BTLA on CD4<sup>+</sup> T cells in patients with chronic hepatitis B virus infection[J]. Viral Immunol, 2010, 23(1):63-70. |
[9] | MOORE C, SAUMA D, REYES PA, et al. Dendritic cells and B cells cooperate in the generation of CD4<sup>+</sup>CD25<sup>+</sup>FOXP3<sup>+</sup> allogeneic T cells[J]. Transplant Proc, 2010, 42(1):371-375. |
[10] | YU XP, GUO RY, SU ML, et al. Dynamic changes of Treg and Th17 cells and related cytokines closely correlate with the virological and biochemical response in chronic hepatitis B patients undergoing nucleos(t)ide analogues treatment[J]. Hepat Mon,2013,13(12):e15332. |
[11] | L?a G, YING L, MA WJ, et al. Dynamic analysis of CD127 expression on memory CD8 T cells from patients with chronic hepatitis B during telbivudine treatment[J]. Virol J, 2010, 7:207-212. |
[12] | 吕红,潘宗琴,胡世芸,等. CD4<sup>+</sup>CD25<sup>+</sup>调节性T细胞与不同HBV感染状态的研究进展[J]. 世界华人消化杂志,2014, 22(10):1373-1377. |
[13] | 孙焕焕,张永宏. T细胞在慢性乙型肝炎发病机制中的作用研究进展[J]. 传染病信息, 2014, 27(4):237-239. |
[14] | 中华医学会肝病学分会,中华医学会感染病学分会. 慢性乙型肝炎防治指南2010年更新版[J]. 中华实验和临床感染病杂志:电子版, 2011, 5(1):79-100. |
[15] | TAN AT, KOH S, GOH V, et al. Understanding the immunopathogenesis of chronic hepatitis B virus: an Asian prospective[J]. J Gastroenterol Hepatol, 2008, 23(6):833-843. |
[16] | 彭国平,孙雯,孙箴. 乙型肝炎病毒感染不同阶段患者外周血CD4<sup>+</sup>CD25<sup>+</sup>调节性T细胞的测定[J]. 中华传染病杂志,2008,26(1):40-45. |